Tai WT - Search Results

1

ASIC3 roles in mechanosensitive elongation of nucleus pulposus cells.

Lim J, Huang SS, Nikkhoo M, Tai WT, Chu YC, Chien A, Wang JL. Lim J, et al. Among authors: tai wt. J Biomech. 2024 Jan;163:111938. doi: 10.1016/j.jbiomech.2024.111938. Epub 2024 Jan 10. J Biomech. 2024. PMID: 38217980

2

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.

Bergaggio E, Tai WT, Aroldi A, Mecca C, Landoni E, Nüesch M, Mota I, Metovic J, Molinaro L, Ma L, Alvarado D, Ambrogio C, Voena C, Blasco RB, Li T, Klein D, Irvine DJ, Papotti M, Savoldo B, Dotti G, Chiarle R. Bergaggio E, et al. Among authors: tai wt. Cancer Cell. 2023 Dec 11;41(12):2100-2116.e10. doi: 10.1016/j.ccell.2023.11.004. Epub 2023 Nov 30. Cancer Cell. 2023. PMID: 38039964

3

Patient Work and Their Contexts: Scoping Review.

Yin K, Jung J, Coiera E, Laranjo L, Blandford A, Khoja A, Tai WT, Phillips DP, Lau AYS. Yin K, et al. Among authors: tai wt. J Med Internet Res. 2020 Jun 2;22(6):e16656. doi: 10.2196/16656. J Med Internet Res. 2020. PMID: 32484449 Free PMC article. Review.

4

Implementation of an innovative surgical pharmacy service to improve patient outcomes-Twelve-month outcomes of the Enhanced Surgical Medicines Optimization Service.

Bansal N, Tai WT, Chen LC. Bansal N, et al. Among authors: tai wt. J Clin Pharm Ther. 2019 Dec;44(6):904-911. doi: 10.1111/jcpt.13014. Epub 2019 Sep 9. J Clin Pharm Ther. 2019. PMID: 31497885

5

Comment on "ALK is a therapeutic target for lethal sepsis".

Blasco RB, Patrucco E, Mota I, Tai WT, Chiarle R. Blasco RB, et al. Among authors: tai wt. Sci Transl Med. 2018 Dec 12;10(471):eaar4321. doi: 10.1126/scitranslmed.aar4321. Sci Transl Med. 2018. PMID: 30541790 Free PMC article.

6

Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].

Chen KF, Tai WT, Hsu CY, Huang JW, Liu CY, Chen PJ, Kim I, Shiau CW. Chen KF, et al. Among authors: tai wt. Eur J Med Chem. 2018 Jan 1;143:2015. doi: 10.1016/j.ejmech.2017.10.053. Epub 2017 Nov 4. Eur J Med Chem. 2018. PMID: 29113744 No abstract available.

7

SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.

Fan LC, Shiau CW, Tai WT, Hung MH, Chu PY, Hsieh FS, Lin H, Yu HC, Chen KF. Fan LC, et al. Among authors: tai wt. Oncogene. 2017 Oct 12;36(41):5768-5769. doi: 10.1038/onc.2017.251. Epub 2017 Jul 17. Oncogene. 2017. PMID: 28714962

8

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.

Su TH, Shiau CW, Jao P, Yang NJ, Tai WT, Liu CJ, Tseng TC, Yang HC, Liu CH, Huang KW, Hu TC, Huang YJ, Wu YM, Chen LJ, Chen PJ, Chen DS, Chen KF, Kao JH. Su TH, et al. Among authors: tai wt. Sci Rep. 2017 May 11;7(1):1728. doi: 10.1038/s41598-017-01572-z. Sci Rep. 2017. PMID: 28496142 Free PMC article.

9

Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".

Tai WT, Cheng AL, Shiau CW, Huang HP, Huang JW, Chen PJ, Chen KF. Tai WT, et al. J Hepatol. 2017 Jun;66(6):1334-1335. doi: 10.1016/j.jhep.2017.02.021. Epub 2017 Mar 13. J Hepatol. 2017. PMID: 28302383 No abstract available.

10

Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.

Liu CY, Tseng LM, Su JC, Chang KC, Chu PY, Tai WT, Shiau CW, Chen KF. Liu CY, et al. Among authors: tai wt. Breast Cancer Res. 2017 Jan 11;19(1):5. doi: 10.1186/s13058-017-0800-2. Breast Cancer Res. 2017. PMID: 28077164 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page